Clinical Trials List
Protocol Number202000037A0
2020-07-01 - 2023-06-30
Phase II
Recruiting1
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Cheng-Lung Hsu Division of Hematology & Oncology
- Hung-Ming Wang Division of Hematology & Oncology
- Tung-Chieh Chang Division of Radiation Therapy
- 廖俊達 Division of Otolaryngology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
90 participants
-
Global
0 participants
